Home/Filings/4/0001209191-23-032996
4//SEC Filing

Jacot Stanley Jr 4

Accession 0001209191-23-032996

CIK 0001469443other

Filed

May 29, 8:00 PM ET

Accepted

May 30, 6:24 PM ET

Size

5.1 KB

Accession

0001209191-23-032996

Insider Transaction Report

Form 4
Period: 2023-05-30
Jacot Stanley Jr
Chief Executive Officer
Transactions
  • Purchase

    Common stock

    2023-05-30$4.31/sh+5,000$21,5505,000 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $4.27 to $4.35. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

Arcadia Biosciences, Inc.

CIK 0001469443

Entity typeother

Related Parties

1
  • filerCIK 0001909085

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 6:24 PM ET
Size
5.1 KB